Israel - English - Ministry of Health

maxima air separation ltd, israel - oxygen - gas - medicinal, compressed - oxygen 21.0 - 22.5 %v/v - oxygen - gas for inhalation

Israel - English - Ministry of Health

maxima air separation ltd, israel - carbon dioxide - gas - medicinal, liquefied - carbon dioxide 99 % - carbon dioxide - -carbon dioxide may be insufflated into the abdominal cavity to distend it to allow the investigation and treatment of intra-abdominal disease-carbon dioxide may be administered through a metered supply, fed into the oxygenator of an extracorporeal circulation of a cardio-pulmonary by-pass system, and when the gas is used for laparoscopic surgery.

Israel - English - Ministry of Health

maxima air separation ltd, israel - oxygen - liquid for inhalation - oxygen 99.5 % - oxygen - oxygen - breathing aid.

Israel - English - Ministry of Health

maxima air separation ltd, israel - oxygen - gas - oxygen 99.5 % - breathing aid.

Israel - English - Ministry of Health

maxima air separation ltd, israel - oxygen - liquid for inhalation - oxygen 99.5 % - breathing aid.

Israel - English - Ministry of Health

maxima air separation ltd, israel - oxygen - gas - oxygen 99.5 % - oxygen - breathing aid.

Israel - English - Ministry of Health

maxima air separation ltd, israel - nitrogen - liquefied gas - nitrogen 99.5 % - nitrogen - liquefied nitrogen for treatment of skin lesions by freezing (cryotherapy).

Israel - English - Ministry of Health

maxima air separation ltd, israel - nitrogen - liquefied gas - nitrogen 99.5 % - nitrogen - liquefied nitrogen for treatment of skin lesions by freezing (cryotherapy).

Israel - English - Ministry of Health

maxima air separation ltd, israel - nitric oxide - gas - medicinal - nitric oxide 0.08 %v/v - nitrous oxide - mixture 800 ppm no in nitrogen, in conjunction with ventilatory support and other appropriate active substances, is indicated:• for the treatment of newborn infants ≥ 34 weeks gestation with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation.• as part of the treatment of peri- and post-operative pulmonary hypertension in adults and newborn infants, infants and toddlers, children and adolescents, ages 0-17 years in conjunction to heart surgery, in order to selectively decrease pulmonary arterial pressure and improve right ventricular function and oxygenation.

Malta - English - Medicines Authority

rowex ltd newtown bantry, co. cork, , ireland - budesonide, formoterol - inhalation powder - budesonide 160 µg formoterol 4.5 µg - drugs for obstructive airway diseases